ONGOING PROJECTS

MMP-2 Interactions with its Substrates

The matrix metalloproteinases  interact with a number of extracellular matrix molecules via discrete functional domains.  For example, a collagen binding domain in  MMP-2  is responsible for most of the interactions of the enzyme with the collagen substrate molecules that it hydrolyses.  This collagen binding domain is composed of three modules with high similarity to the type II modules also present in the collagen binding domains of fibronectin.  We have earlier characterized the contribution of the collagen binding domain of MMP-2 to interactions with several of its substrates (J. Biol. Chem. 1995).  Importantly, this domain may also contribute importantly to the positioning of the enzyme both in the extracellular matrix and on cell surfaces.  Therefore, we have investigated the role of the MMP-2 collagen binding domain in mediating enzyme interactions with pericellular matrix molecules and showed that it constitutes an additional mechanism for cell surface positioning of the enzyme (J. Biol. Chem., 1998).  Continuing this line of research and to further understand the molecular basis for collagen interactions with fibronectin-like type II modules, we have analyzed and mapped interactions of recombinant proteins corresponding to different parts of the collagen binding region of fibronectin (Matrix Biology 2002).  These experiments have enabled us to define the relative importance of substrate size and binding to MMP-2 (Matrix Biol. 2004), the functional basis for MMP-2 and MMP-9 ligand interactions and substrate specificities (Biochemical J. 2005), and the contribution of MMP-2 to cancer cell migration (Cancer Res. 2005).  Using peptide library screening, we have identified an essential binding site for MMP-2 on type I collagen and have used a collagen-derived peptide to specifically block MMP-2 interactions with collagen and block the cleavage of this substrate (Biochemical J. 2007).  Recently, we have engaged in detailed studies of the mechanism of fibronectin cleavage and the biology of  fibronectin fragments.

As an integral part of ongoing funding from NIH (2001-2011), we are pursuing our studies in  interdisciplinary collaborative efforts with colleagues in the UTHSCSA Department of Biochemistry, Center for Biomolecular Structure Analysis and Laboratory for Mass Spectrometry.

Matrix Metalloproteinases (MMPs) in Health and Disease

We welcome collaborations, and in several collaborative efforts, we are investigating the roles of MMPs and matrix degradation in health and disease

Matrix molecules are degraded during such conditions as periodontal disease, abnormal wound healing, and cancer.  We are extending the observations on the fibronectin fragmentation in the context of wound healing with emphasis on the effects on cell behavior and cell associated enzyme activation (Matrix Biology 2002 and Matrix Biology 2004).  To understand the potential role of MMPs in hydrolysis of fibronectin, we are applying modern proteomics technics to explore the protein-MMP interactions.

To investigate the roles of MMPs and matrix degradation in altered wound healing in diabetes, we have developed an active interdisciplinary collaboration with colleagues in UTHSCSA* Department of Orthopedics, Division of Podiatry and Texas Diabetes Institute, a facility devoted to management of patients with diabetes in San Antonio and South Texas.  We are analyzing samples from patients suffering from diabetes mellitus, who are particularly prone to poorly healing wounds and extensive periodontal disease.  Funding for this effort has been granted from the South Texas Health Research Center. 

To  enhance our analysis of patient samples, we are integrating analyses with state-of-the art techniques to quantify enzyme activities in biological fluids. 


In addition, we are currently in the preliminary phases of projects, which investigate the significance of MMPs in heart disease.  These projects involve collaborations with colleagues in the UTHSCSA Departments of Medicine, Division of Cardiology.  Dr. Bjorn Steffensen is affiliated with San Antonio Cancer Institute, an organization central to coordinating the cancer related research in the San Antonio area.

*  UTHSCSA, University of Texas Health Science Center at San Antonio


Committed to seeking solutions!